Personal profile
Personal profile
Treatment Philosophy
I am a medical oncologist specializing in genitourinary cancers. Treating patients with cancer is a privilege for me as in the process of diagnosing and treating the illness I get to become the patient’s friend, resource and advocate. In the most difficult times of their life, each cancer patient and their family deserves the best possible care. I strive to provide excellent care by being a good listener, maintaining good communication with patients and my team, staying abreast with the rapidly evolving field of oncology and by providing individualized care to each patient.
I came to Fox Chase for my fellowship and stayed here because I loved the team and realized that at Fox Chase, each patient has the benefit of an interdisciplinary team working together to ensure the highest quality care. This team approach is crucial in determining and implementing the best treatment plan.
In my clinical practice I focus on the care of patients with kidney, prostate bladder, penile, adrenal and testicular cancer and I am proud to be part of a large multidisciplinary team of distinguished clinicians and researchers at Fox Chase. Over the last decade, the number of treatment options for patients with advanced cancers has greatly expanded and at Fox Chase we can offer both the latest standard-of-care as well as new experimental approaches. My particular research interest is in developing biomarkers that can help understand the behavior of kidney cancers as well as clinical trial development for genitourinary cancers.
Areas of Expertise
Prostate Cancer, Urethral Cancer, Adrenal Tumor, Penile Cancer, Ureteral Cancer, Kidney Cancer, Testicular Cancer, Bladder Cancer
Treatment Focus
Chemotherapy, targeted chemotherapy, immunotherapy, hormone therapy, clinical trials for genitourinary malignancies
Personal profile
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
20 years of histone lysine demethylases: From discovery to the clinic and beyond
Gray, Z. H., Honer, M. A., Ghatalia, P., Shi, Y. & Whetstine, J. R., Apr 3 2025, In: Cell. 188, 7, p. 1747-1783 37 p.Research output: Contribution to journal › Review article › peer-review
9 Scopus citations -
A Practical Guide for the Management of Toxicities Associated with Belzutifan
Li, J. & Ghatalia, P., May 2025, In: European Urology Focus. 11, 3, p. 408-410 3 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Comparison of Outcomes Between African American and European American Patients With Metastatic Clear Cell Renal Cell Carcinoma Receiving Immune Checkpoint Inhibitors
Kaur, J., Hasler, J. S., Handorf, E. A., Zibelman, M. R., Anari, F., Geynisman, D. M. & Ghatalia, P., Apr 2025, In: Clinical Genitourinary Cancer. 23, 2, p. 102304 102304.Research output: Contribution to journal › Article › peer-review
-
Correction to: REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens
Zhong, J., Jang, A., Abuqayas, B., Basu, A., Benjamin, D. J., Bhatlapenumarthi, V., Bilen, M. A., Buch, D., Chang, M., Chin, E., Darabi, S., Dhanikonda, N., Ghatalia, P., Grigg, C. M., Grier, A. L., Jindal, T., Jung, J., Kilari, D., Kumar, H. L. S. & Lee, S. & 13 others, , Oct 1 2025, In: Oncologist. 30, 10, 1 p., oyaf302.Research output: Contribution to journal › Article › peer-review
-
From surgery to systemic therapy: long-term lessons of belzutifan in von Hippel-Lindau disease
Schnoll, M. & Ghatalia, P., Nov 30 2025, In: Translational Andrology and Urology. 14, 11, p. 3437-3439 3 p.Research output: Contribution to journal › Comment/debate
Open Access
Press/Media
-
Can ctDNA Negativity Predict Metastasis-Free Survival in Muscle-Invasive Bladder Cancer?
03/3/26
1 item of Media coverage
Press/Media
-
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery
03/2/26
1 item of Media coverage
Press/Media
-
Simple blood test may help some bladder cancer patients skip surgery
03/2/26
1 item of Media coverage
Press/Media
-
Blood Test Predicts Which Bladder Cancer Patients May Skip Surgery
02/28/26
1 item of Media coverage
Press/Media
-
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery
02/27/26 → 02/28/26
4 items of Media coverage
Press/Media